News | September 17, 2014

Pediatric Brain Tumor Patient From the U.K. Undergoes First Treatment of Proton Therapy

After controversial withdrawal from Southampton General Hospital, Ashya King begins treatment in Prague

Ashya King's prescribed treatment plan for proton therapy

A version of Ashya King's treatment plan using conventional radiation therapy

September 17, 2014 — Five-year-old Ashya King, the brain tumor patient whose case made headlines in Europe after his parents unlawfully took him from his hospital in Southampton, England, against the advice of doctors, began undergoing his prescribed treatment plan for proton therapy this week.

King was previously under the care of Southampton General Hospital for treatment of medulloblastoma. After unsatisfaction with the hospital’s treatment plan, King’s father sought more effective approaches through the Internet and came upon proton therapy. When the hospital refused to attempt it on King, his parents fled the United Kingdom to find a hospital that would, sparking a controversial debate.

The boy is now under the care of Motol University Hospital, where he is staying while undergoing treatment at the Proton Therapy Centre Czech in Prague. The overall course of treatment will take place over 30 visits; the first 13 will be to deliver irradiation to the entire tumor area—including the spinal cord, to ensure it is not spreading via cerebrospinal fluid—while the following 17 will be to treat just the tumor volume.

“There is a 70 to 80 percent survival rate for the condition such as the one Ashya has, and there is now every reason to hope that he will make a full recovery,” said his attending physician, Barbora Ondrová, M.D.

To illustrate the differences between proton therapy and conventional radiation therapy, the specialists at Proton Therapy Centre Czech drew up treatment plans for both techniques. In King’s case, it is necessary to apply the highest possible dose into the tumor but protect the tissue around it as much as possible. Vital structures to be protected include the heart, lung, liver and intestines. This means decreasing the risk of developing cardiovascular disorders, breathing disorders or metabolic disorders, and better protection of the swallowing functions and normal food intake.

For more information: www.ptc.cz

Related Content

SpaceOAR Hydrogel Now Available in Japan
News | Patient Positioning Radiation Therapy | July 16, 2018
Augmenix K.K. announced that SpaceOAR hydrogel, a soft, implanted absorbable gel spacer is now available to all...
RaySearch Releases New Version of RayCare OIS
Technology | Oncology Information Management Systems (OIMS) | July 13, 2018
RaySearch has released RayCare 2A, the latest version of its flagship oncology information system (OIS). RayCare is...
Lack of Insurance Coverage Delaying Proton Therapy Clinical Trials
News | Proton Therapy | July 12, 2018
Randomized clinical trials are the gold standard of cancer research and can shed light on whether innovative, new...
Bruce Power Joins Forces With ITM to Supply Lutetium-177 for Cancer Therapy
News | Radiation Therapy | July 11, 2018
Canadian nuclear power company Bruce Power and German-based Isotope Technologies Garching (ITG) signed an agreement to...
MedStar Georgetown University Hospital Now Clinical With RayStation and Hyperscan
News | Treatment Planning | July 05, 2018
MedStar Georgetown University Hospital in Washington D.C., has begun patient treatments using the RayStation treatment...
Northern Centre for Cancer Care (NCCC)

Northern Centre for Cancer Care (NCCC).

Sponsored Content | Case Study | Radiation Therapy | July 05, 2018
Established in 2009, Northern Centre for Cancer Care (NCCC) is the largest center of its kind in the north of England....
Feature | Treatment Planning | July 03, 2018 | By Jeff Zagoudis
A new software developed and recently tested at the MD Anderson Cancer Center demonstrated the ability to largely aut
Researcher Investigates Eliminating Radiation for HER2-Positive Breast Cancer
News | Radiation Therapy | July 02, 2018
Researchers at The University of Kansas Cancer Center have launched a clinical trial that eliminates radiation from the...
New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Overlay Init